Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Private-label manufacturing.

R Lally1

  • 1Product Certification Division, British Standards Institution (BSI), London, UK.

Medical Device Technology
|November 3, 1997
PubMed
Summary

Private labelling offers market access but requires Medical Device Directive compliance. This article explores solutions to compliance responsibility confusion for manufacturers and distributors.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Age, gender, and education norms on the CERAD neuropsychological battery in the oldest old.

Neurology·2006
Same author

Successful use of a quality improvement team to reduce ventilator-associated pneumonia.

Critical care nurse·1998
Same author

Achieving systematic compliance with the Medical Device Directive.

Medical device technology·1996
Same author

Clumping factor defective methicillin-resistant Staphylococcus aureus.

European journal of clinical microbiology·1984

Area of Science:

  • Regulatory Affairs
  • Medical Device Compliance
  • Product Labelling

Background:

  • Private labelling allows manufacturers market access and distributors brand enhancement.
  • Challenges arise in ensuring private-labelled products meet Medical Device Directive (MDD) standards.
  • Ambiguity exists regarding responsibility for compliance issues in private labelling.

Purpose of the Study:

  • To examine the complexities of Medical Device Directive compliance for private-labelled products.
  • To explore proposed solutions for clarifying compliance responsibility.
  • To outline key requirements for ensuring product compliance.

Main Methods:

  • Review of regulatory frameworks concerning private labelling.
  • Analysis of compliance responsibility models.
  • Identification of essential elements for MDD adherence.

Main Results:

  • Private labelling presents regulatory challenges, particularly concerning the Medical Device Directive.
  • Confusion over compliance responsibility can hinder market entry.
  • Clearer frameworks are needed to assign accountability.

Conclusions:

  • Addressing compliance responsibility is crucial for successful private labelling in the medical device sector.
  • Manufacturers and distributors must proactively manage regulatory requirements.
  • Adherence to the Medical Device Directive is paramount for patient safety and market access.

Related Experiment Videos